See more : V.F. Corporation (VFC) Income Statement Analysis – Financial Results
Complete financial analysis of Cronos Group Inc. (CRON) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cronos Group Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Greenlane Holdings, Inc. (GNLN) Income Statement Analysis – Financial Results
- China Railway Construction Corporation Limited (1186.HK) Income Statement Analysis – Financial Results
- California Resources Corporation (CRC) Income Statement Analysis – Financial Results
- Yibin Tianyuan Group Co., Ltd. (002386.SZ) Income Statement Analysis – Financial Results
- Shandong Bohui Paper Industry Co., Ltd. (600966.SS) Income Statement Analysis – Financial Results
Cronos Group Inc. (CRON)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.thecronosgroup.com
About Cronos Group Inc.
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 87.24M | 91.90M | 74.44M | 46.72M | 23.75M | 11.53M | 3.25M | 412.32K | 0.00 | 0.00 | -195.61K |
| Cost of Revenue | 75.33M | 79.94M | 91.97M | 72.55M | 41.61M | 3.26M | 1.98M | 1.44M | 144.98K | 32.16K | 0.00 |
| Gross Profit | 11.91M | 11.97M | -17.53M | -25.83M | -17.86M | 8.27M | 1.27M | -1.03M | -144.98K | -32.16K | -195.61K |
| Gross Profit Ratio | 13.65% | 13.02% | -23.56% | -55.29% | -75.22% | 71.76% | 39.08% | -249.00% | 0.00% | 0.00% | 100.00% |
| Research & Development | 5.84M | 13.38M | 23.33M | 20.37M | 12.16M | 1.73M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 58.23M | 86.29M | 106.63M | 95.89M | 60.99M | 15.90M | 7.00M | 2.78M | 1.47M | 2.02M | 0.00 |
| Selling & Marketing | 22.70M | 22.28M | 44.94M | 34.39M | 23.05M | 3.02M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 80.93M | 108.58M | 151.57M | 130.28M | 84.04M | 18.92M | 7.00M | 2.78M | 1.47M | 2.02M | 423.86K |
| Other Expenses | 9.93M | 6.03M | 4.48M | 2.87M | 2.10M | 922.15K | 430.22K | 284.76K | 81.66K | 207.54K | 0.00 |
| Operating Expenses | 96.71M | 127.98M | 179.39M | 153.51M | 98.29M | 21.57M | 7.43M | 3.07M | 1.55M | 2.22M | 423.86K |
| Cost & Expenses | 172.04M | 207.92M | 271.35M | 226.07M | 139.91M | 24.82M | 4.92M | 2.00M | 1.69M | 2.26M | 423.86K |
| Interest Income | 51.24M | 22.54M | 9.07M | 18.60M | 28.62M | 0.00 | 3.20K | 4.92K | 29.97K | 0.00 | 0.00 |
| Interest Expense | 0.00 | 22.54M | 27.00K | 186.00K | 27.98M | 78.56K | 100.20K | 177.27K | 325.17K | 0.00 | 0.00 |
| Depreciation & Amortization | 8.26M | 13.12M | 15.40M | 7.05M | 3.91M | 1.84M | 792.05K | 284.76K | 81.66K | 28.11K | 0.00 |
| EBITDA | -72.15M | -91.27M | -192.28M | -70.40M | -1.41B | -18.85M | -5.35M | -1.17M | 559.96K | -3.25M | -619.48K |
| EBITDA Ratio | -82.70% | -64.40% | 29.81% | -342.66% | -5,917.22% | -100.74% | -23.20% | -284.94% | 0.00% | 0.00% | 316.69% |
| Operating Income | -84.80M | -116.01M | 6.79M | -179.35M | -121.48M | -13.29M | -1.68M | -1.23M | 540.34K | -3.08M | -619.48K |
| Operating Income Ratio | -97.20% | -126.23% | 9.12% | -383.88% | -511.51% | -115.32% | -51.64% | -297.13% | 0.00% | 0.00% | 316.69% |
| Total Other Income/Expenses | 11.13M | -18.55M | 129.46M | 1.35M | 1.29B | -478.00K | 3.78M | -82.85K | -344.79K | -1.11M | 0.00 |
| Income Before Tax | -73.67M | -134.56M | -397.14M | -73.27M | 1.17B | -13.74M | 2.22M | -1.31M | 155.05K | -4.15M | -619.48K |
| Income Before Tax Ratio | -84.44% | -146.41% | -533.53% | -156.84% | 4,907.68% | -119.19% | 68.32% | -317.23% | 0.00% | 0.00% | 316.69% |
| Income Tax Expense | -3.23M | 34.18M | -431.00K | 1.35M | -1.29B | 359.02K | 236.98K | -422.59K | -123.23K | 2.99M | 0.00 |
| Net Income | -73.96M | -168.73M | -396.70M | -74.62M | 2.46B | -13.93M | 1.98M | -885.40K | 278.28K | -4.15M | -619.48K |
| Net Income Ratio | -84.78% | -183.60% | -532.95% | -159.72% | 10,338.43% | -120.80% | 61.02% | -214.74% | 0.00% | 0.00% | 316.69% |
| EPS | -0.19 | -0.45 | -1.07 | -0.21 | 7.92 | -0.08 | -0.01 | -0.01 | 0.01 | -0.13 | -0.05 |
| EPS Diluted | -0.19 | -0.45 | -1.07 | -0.21 | 7.16 | -0.08 | -0.01 | -0.01 | 0.01 | -0.13 | -0.05 |
| Weighted Avg Shares Out | 380.96M | 376.96M | 370.39M | 351.58M | 310.07M | 172.27M | 134.80M | 78.25M | 36.41M | 31.95M | 12.75M |
| Weighted Avg Shares Out (Dil) | 380.96M | 376.96M | 370.39M | 351.58M | 342.81M | 172.27M | 176.79M | 78.25M | 43.69M | 32.24M | 12.75M |
3 Marijuana Stocks For Your Holiday Trading
What are marijuana stock investors searching for this holiday season? For starters, some companies have recently reported strong quarterly earnings. The better a company performs, the more intriguing it looks to people to invest in it. Right now, many cannabis...
Why Cronos Group Stock Popped 9% Today
Cronos stock just went up -- a lot. Maybe it's time to sell?
Cronos Group Inc. (CRON) Q3 2024 Earnings Call Transcript
Cronos Group Inc. (NASDAQ:CRON ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Anna Shlimak - Chief Strategy Officer Mike Gorenstein - Chairman, President and CEO James Holm - CFO Conference Call Participants Matt Bottomley...
Cannabis stocks plunge after DeSantis, Griffin win Florida fight against weed legalization
Amendment 3 – which would have legalized the recreational use of marijuana in the state's constitution – failed to receive the 60% support needed to pass under Florida law.
Cannabis stocks tank as Florida votes against recreational marijuana
Shares in cannabis stocks such as Trulieve Cannabis Corp. (CSE:TRUL), Curaleaf Hldgs Inc. (CSE:CURA, OTCQX:CURLF) and Verano Holdings Corp (CSE:VRNO, OTCQX:VRNOF) tanked after Florida rejected legalization of recreational marijuana. A ballot measure, known as Amendment 3, which would have allowed adults to possess up...
Top Canadian Cannabis Stocks to Track as U.S. Legalization Heats Up
As the election approaches, Canadian cannabis stocks are capturing attention, especially with potential U.S. legalization developments on the horizon. The U.S. cannabis industry is booming, with projected growth reaching $41 billion by 2025. This massive market is appealing to Canadian...
5 Stocks Backed by High Efficiency for Solid Gains Amid Volatility
Invest in stocks of AMRX, CRON, CSV, BFST and APH to tap their high-efficiency levels.
Cronos Group Inc. to Hold 2024 Third Quarter Earnings Conference Call on November 12, 2024
TORONTO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 third quarter earnings conference call on Tuesday, November 12, 2024 at 8:30 a.m. ET. Cronos' senior management team...
Spinach® Is the Number One Cannabis Brand in Canada
TORONTO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, is proud to announce that its award-winning brand Spinach® has risen to the best-selling cannabis brand in the Canadian market.1...
3 Cannabis Stocks to Monitor as the Election Approaches
For most of the campaign cycle, those bullish on cannabis stocks viewed a Vice President Kamala Harris presidency as the most beneficial to the sector.
Source: https://incomestatements.info
Category: Stock Reports